In 2016, Catalonia experienced a pediatric brainstem encephalitis outbreak caused by 45 enterovirus A71 (EV-A71). Conventional testing identified EV in peripheral body sites, but EV 46 was rarely identified in cerebrospinal fluid (CSF). RNA was extracted from CSF (n=20), plasma 47 Samples were received frozen and stored at -80C. RNA isolation from CSF, serum and NP 130 samples was performed using the RNeasy Micro kit (Qiagen, Germantown, MD). Serum, stool 131 and NP samples were first homogenized with OMNI-International's 2.8mm ceramic bead kit and 132 the Tissuelyzer II (Qiagen) for 5 min at 15Hz. Stool was extracted using the RNeasy 133
Using phylogenetic analysis, the outbreak EV-A71 clustered with a neuroinvasive German EV-58 A71 isolate. Brainstem encephalitis specific, non-synonymous EV-A71 single nucleotide variants 59
were not identified. mNGS demonstrated 100% concordance with clinical qRT-PCR of EV-60 related brainstem encephalitis and significantly increased the detection of enteroviruses. Our 61 findings increase the probability that neurologic complications observed were virus-induced 62 rather than para-infectious. A comprehensive genomic analysis confirmed that the EV-A71 63 outbreak strain was closely related to a neuroinvasive German EV-A71 isolate. There were no 64 Introduction 67
In early 2016, an outbreak of enterovirus A71 (EV-A71) in Catalonia caused more than 100 68 pediatric cases of neurological disease, ranging from aseptic meningitis to brainstem 69 encephalitis with or without myelitis (1) . Virological studies of peripheral body fluids (excluding 70 cerebrospinal fluid [CSF]) identified EV-A71 in almost all patients, but other EVs were also found 71 by EV quantitative reverse transcription polymerase chain reaction (qRT-PCR) during the 72 outbreak, including echovirus-30 (E-30), coxsackievirus (CV)-B1, and CV-A10. The EV-A71 strain 73 was subtyped as subgenogroup C1, and phylogenetic analyses showed it was closely related to 74 an EV-A71 strain associated with a 2015 case of brainstem encephalitis (2, 3). Similar outbreaks 75 occurred in France and Denmark around the same time period (4, 5). EV-A71 was identified 76 from the CSF of 0.02% of patients in the German study, 3% in the Danish study, and 14% in the 77 French study. 78 Despite this information, questions remained about the Catalonia outbreak. In particular, 79 the EV-A71 subgenotype was only identified by standard testing in the CSF of 11% of patients, 80 all of whom had aseptic meningitis (1, 6) , raising the possibility that although almost all the 81 children had a documented systemic EV-A71 infection, their neurological sequelae may have 82 been caused by a para-infectious mechanism or by an unidentified co-infection. In addition, 83 standard qRT-PCR assays only recovered a small segment of the EV-A71 genome, limiting the 84 ability to assess for mutations in the virus genome that may have conferred increased 85 neurovirulence. 86 Metagenomic next-generation sequencing (mNGS) of CSF is an assay that can 87 simultaneously identify a broad range of infectious agents -viruses, fungi, bacteria and 88 parasites -in patients with neurological symptoms. As opposed to traditional pathogen-specific 89 PCR assays which amplify only limited regions of a microbe's genome, the entire genome of a 90 pathogen can often be rapidly surveyed with mNGS, making it possible to identify genomic 91 changes in the virus that may correlate with increased neurovirulence or reveal strain 92 divergence (7) . Here, we deployed unbiased mNGS of CSF, nasopharyngeal (NP) samples, 93 plasma and stool obtained from affected children during the Catalonia brainstem encephalitis 94 outbreak to screen for additional pathogens (including co-infections) and to compare EV 95 genomes in patients with brainstem encephalitis to patients with more benign neurologic 96 disease (i.e. meningitis with or without encephalitis with self-limited and short-lasting 97 symptoms). 98 99
Methods 100
Cohort 101
The first 10 cases diagnosed with brainstem encephalitis or encephalomyelitis with 102 available residual specimen were included as cases, and the first 10 patients with aseptic 103 meningitis or uncomplicated encephalitis diagnosed during the same period were selected as 104 controls. All of these children were admitted to a tertiary pediatric hospital (Hospital Sant Joan 105 de Deu, University of Barcelona) from April to June 2016. Hospital Sant Joan de Deu is a 300-106 bed tertiary care hospital for high-complexity patients across a catchment area with a pediatric 107 population of ~300,000 and has participated in a Spanish EV molecular surveillance network 108 since 2010. 109 EV-related neurological disease was defined as the detection of EV in any sample in the 110 absence of other causes. The clinical diagnostic approach during the outbreak was previously 111 described (1) PCR is a one-step RT-PCR amplification with EV primers and probes targeted at a conserved 121 region of the 5' untranslated region, with a limit of detection of 592 genomic equivalents/mL of 122 CSF (9, 10). Patients 1, 3-7 and 9-10, defined as cases, were also negative by the BioFire 123 Sequences were analyzed using a rapid pathogen identification computational pipeline 147 developed by the DeRisi Laboratory, described previously in detail (14) . Sequences that mapped 148 to the EV genus were collected and de novo assembled using the Geneious and/or St. 149
Petersburg genome Assembler (SPAdes) algorithms (15). Phylogenetic trees were created in 150 Geneious v10.2.3 using a MUltiple Sequence Comparison by Log-Expectation (MUSCLE) or 151
Multiple Alignment using Fast Fourier Transform (MAFFT) alignment algorithm followed by the 152 Geneious Tree Builder tool, using the Neighbor-Joining build method (16, 17) . Bootstrap 153 analysis for each tree was performed with 100 replicates. For single nucleotide variant (SNV) 154 analysis, Bowtie2 v2.3.3 was used to map reads to a reference and then analyzed using VarScan 155 v2.3.4 (18, 19) . Statistics on the degree of concordance between research-based mNGS results 156 and standard clinical diagnostic testing results were performed using McNemar's statistical test. 157
Results 158

Clinical Testing vs mNGS 159
We obtained an average of 21.8 million (4.53-61.1 million) 140 bp paired-end reads per sample 160 (Supplemental Figure 1) . The non-human sequence reads from each sample have been 161 deposited at the National Center for Biotechnology Information (NCBI) Sequence Read Archive, 162
BioProject (pending). The water controls for CSF and NP samples contained no EV reads. The 163 water control for the stool samples had 0.7 EV rpm when it was pooled and sequenced 164 together with many high EV titer stool samples. To differentiate whether the EV reads present 165 in the stool water control stemmed from physical cross contamination or from bioinformatic 166 contamination due to barcode misassignment (that still occurs at very low levels despite a dual 167 index barcoding strategy) (20), we re-sequenced the same stool water control library separate 168 from high EV titer samples. When sequenced separately, we found no EV reads in this water 169 control. This suggested that the small number of EV reads in the first dataset stemmed from 170 barcode misassignment from the high EV titer samples and not from physical cross 171 contamination. In addition, we re-sequenced the patient samples (NP samples from patients 1, 172 9, 16 and 18) whose EV read abundance fell below the abundance level of the stool water 173 control on the first sequencing run to similarly determine whether the EV reads were present 174 due to barcode misassignment. Unlike the stool water control, when these patient samples 175
were re-sequenced, they retained EV reads, providing evidence that EV was indeed present in 176 these samples. 177
Of the 10 cases and 10 controls investigated, EVs were detected in CSF, NP and stool 178 samples via mNGS ( Figure 1 ). Overall, mNGS was concordant with the positive qRT-PCR results 179
for EVs (25 of 25). In the samples found to be EV-negative by clinical Pan-EV qRT-PCR (n=35), 180 pathogens were detected in 28.6% (n=10) Genbank MH484066-MH484076) were assembled as described in Methods. All 6 EV-A71 194 genomes were nearly identical to the German neuroinvasive EV-A71 strain (Genbank 195 KX139462.1, 99.3-99 .4% nucleotide similarity and 99.7-99.8% amino acid similarity) ( Figure  196 2b). In addition, we corroborated the previously published phylogenetic analysis that used a 197
Sanger sequence of 360 bases in the 3' end of the VP1 region, by comparing the entire VP1 198 gene from our full-length EV-A71 genomes to the VP1 sequences from 11 German 199 neuroinvasive EV-A71 strains, 17 neurovirulent Chinese EV-A71 strains, 6 contemporary, 200 neurovirulent African strains and 26 EV-A71 strains associated with hand foot and mouth 201 disease in Spain (21-24). 202
Next, 8,841 full length EV genomes were clustered at 95% similarity to create a list of 535 203 sequences. The EV-A71, E-30 and CV-B strains were aligned to the clustered list using a MAFFT 204 alignment algorithm, followed by phylogenetic analysis. All 3 viruses appropriately clustered 205 within their own species ( Figure 2C) . 206
Lastly, SNV analysis was performed on the full-length EV-A71 genomes (3 from patients with 207 brainstem encephalitis, 2 from patients with meningitis and 1 from a patient with encephalitis) 208 to identify SNVs unique to brainstem encephalitis patients. We identified 55 inter-host SNVs 209 that were unique to the EV-A71s associated with brainstem encephalitis. Only 2 of those SNVs 210 were common to all 3 viruses (Supplemental Figure 2 ). However, both of these SNVs were 211 synonymous mutations located in the 3A and 3D genes, and thus the biological significance of 212 these mutations, if any, is uncertain (25). 213
Discussion 214
The original description of the 2016 pediatric brainstem encephalitis outbreak in Catalonia 215 identified EV-A71 as the likely etiologic agent. However, this conclusion was tempered because 216 1) there were multiple other co-circulating EVs present during the outbreak, and 2) EV-A71 was 217 not identified in the CSF of the vast majority of patients with brainstem encephalitis. Identifying 218 EVs in peripheral body sites of patients with severe neurologic disease but failing to find it in 219 the CNS mirrors both the recent North American outbreak of acute flaccid myelitis associated 220 with EV-D68 (26) and in an EV-A71 outbreak in the early 2000s (27) . As a result, others have 221 hypothesized that the severe neurologic sequelae experienced by children in both outbreaks 222 may have been due to a para-infectious mechanism (or a co-infection) rather than as a direct 223 effect of the virus. Here, we utilized mNGS to further investigate patient samples from the 224 Catalonia outbreak to address these hypotheses. 225
In contrast to EV-specific qRT-PCR, mNGS identified EV-A71 in the CSF of 4 patients (20%), 1 226 with brainstem encephalitis, 1 with simple encephalitis, and 2 with meningitis alone. EV-A71 227 abundance levels in the CSF were very low (0.03-0.55 rpm), and only 3.6% (2/56) of reads 228 mapped to the 5'UTR (the area of the EV genome targeted by the clinical qRT-PCR assay). This 229 may explain the lower sensitivity of the clinical qRT-PCR assay and the BioFire FilmArray panel 230 (1, 6) . 231
With regard to co-infections, we identified HHV-7 in the CSF of 1 patient with brainstem 232 encephalitis who also had EV-A71 identified in the NP sample and stool. There is controversy 233 about the neuro-pathogenicity of HHV-7, although there are a number of reported cases of 234 HHV-7 encephalitis both in immunocompromised and immunocompetent children, including 235 children with brainstem encephalitis (28). In addition, mNGS also identified 5 patients co-236 infected by 2 different EVs, and 2 of these patients had severe clinical phenotypes, raising the 237 possibility that co-infection may have contributed to disease severity. These findings highlight 238 that in the midst of an outbreak, mNGS can identify patients with alternate or co-infections that 239 produce clinical phenotypes mimicking or contributing to the phenotype associated with the 240 outbreak pathogen. 241 A limitation of this paper is that, due to sample availability, we did not perform orthogonal 242 confirmation of the mNGS-only virus identifications. As a result, our evaluation of the 243 performance of the mNGS assay is vulnerable to incorporation bias because the gold standard 244 by which we are evaluating its performance includes the mNGS results (29) . However, for 245 reasons described above in Results, we are confident that even the low levels of virus detected 246 by mNGS were not due to physical contamination and/or barcode misassignment. 247 Through mNGS, we were able to recover significantly more genetic information about the 248 EV-A71 outbreak strain, including 6 full-length genomes. This additional information 249 corroborated that the EV-A71 strain was nearly identical to the 2015 neuroinvasive German 250 strain as opposed to the much more common outbreaks of EV-A71-associated brainstem 251 encephalitis seen throughout Asia (Figure 2b-c) . Indeed, we found that the strain circulating in 252
Catalonia was more closely related to recently reported contemporary West African strains 253 than Chinese strains (21) (Figure 2b) . Despite having full-length genomes, we were unable to 254 identify the presence of any novel or previously known SNVs that might be associated with 255 increased neurovirulence in this limited cohort. Of note, mutations in the 3A (membrane 256 binding protein important in replication) and 3D (the RNA-dependent RNA polymerase) genes 257 have been identified as important regions for adaption to a neuroblastoma cell line (25). In 258 these 2 genes, we identified 1 synonymous SNV in each, common to 3 EV-A71 genomes from 259 brainstem encephalitis patients but not found in meningitis/encephalitis patients. We also 260 searched for a VP1-31G SNV recently reported to be associated with EV-A71 strains with 261 neuroinvasive potential (30). This SNV was not identified in any of the 6 EV-A71 genomes. 262
Despite this, we believe these data will serve as a valuable resource for future studies that seek 263 to identify the genetic determinants of neuroinvasive EV-A71 infections. 264
While there have been many case reports and small case series documenting the ability of 265 mNGS to detect a variety of pathogens in the CSF (14, 31-33), there have been very few reports 266 on the actual diagnostic yield of mNGS of CSF compared to traditional assays, including 267 pathogen-specific PCR and the BioFire FilmArray. This study demonstrates that in a cohort of 268 patients with a variety of viral CNS infections, a single mNGS assay was concordant with positive 269 pathogen-specific PCR results and indeed, more sensitive for the detection of EV across all 270 sample types, especially in the CSF. Furthermore, identifying EV-A71 in the CSF of 4 additional 271 patients provides circumstantial evidence that this strain was may be neuroinvasive and that a 272 para-infectious etiology is a less likely explanation for the neurological phenotypes observed 273 during the outbreak. Lastly, the rich viral genomic datasets generated by mNGS enabled more 274 sophisticated analyses about the origins of the outbreak strain and the search for possible 275 neurovirulence factors. While the experiments described herein utilized a research-based CSF 276 mNGS assay, a clinically validated CSF mNGS assay with a 3-7 day turnaround time was recently 277 evaluated in a multi-center prospective study and is now clinically available (34). Thus, this type 278 of unbiased diagnostic approach is no longer relegated only to research settings, and its role in 279 individual patient care and public health outbreak investigations will likely expand. PI15CIII-00020] and The European Regional Development Fund (FEDER funds). 290
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